Report #2837042

Received Apr 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 51 yrs
State: —
Recovered: Recovered
Vaccinated: Jan 16, 2022
Onset: Jan 16, 2022
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Lip swelling

Symptom narrative

Swelling of lips; This non-serious case was reported by a consumer and described the occurrence of lip swelling in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 16-JAN-2022, the patient received Shingrix. On 16-JAN-2022, less than a day after receiving Shingrix, the patient experienced lip swelling (Verbatim: Swelling of lips). On 16-JAN-2022, the outcome of the lip swelling was resolved. It was unknown if the reporter considered the lip swelling to be related to Shingrix. It was unknown if the company considered the lip swelling to be related to Shingrix. Additional Information: GSK Receipt Date: 13-APR-2025 Reporter wanted to know what the ingredients are in vaccine, so they can check future vaccines. Patient had swelling of lips and it was treated.